Real-world adherence to, and persistence with, once- and twice-daily oral disease-modifying drugs in patients with multiple sclerosis: a systematic review and meta-analysis

BACKGROUND: Nonadherence to disease-modifying drugs (DMDs) for multiple sclerosis (MS) is associated with poorer clinical outcomes, including higher rates of relapse and disease progression, and higher medical resource use. A systematic review and quantification of adherence and persistence with ora...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicholas, Jacqueline A., Edwards, Natalie C., Edwards, Roger A., Dellarole, Anna, Grosso, Megan, Phillips, Amy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371467/
https://www.ncbi.nlm.nih.gov/pubmed/32664928
http://dx.doi.org/10.1186/s12883-020-01830-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371467/
https://www.ncbi.nlm.nih.gov/pubmed/32664928
http://dx.doi.org/10.1186/s12883-020-01830-0

Ejemplares similares